Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$32.47-5.67%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · HRMY
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 989.4 | 868.5 | 714.7 | 582.0 | 437.9 | 305.4 | 159.7 |
| Cost of Revenues | 256.9 | 198.3 | 156.8 | 121.2 | 83.5 | 55.5 | 27.7 |
| Gross Profit | 732.4 | 670.1 | 557.9 | 460.8 | 354.4 | 249.9 | 132.0 |
| Operating Expenses & Income | |||||||
| R&D Expenses | 237.6 | 189.6 | 145.8 | 76.1 | 70.9 | 30.4 | 19.4 |
| Operating Income | 219.4 | 208.5 | 190.8 | 192.0 | 120.2 | 87.5 | 17.0 |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 14.6 | 17.5 | 23.8 | 18.8 | 24.2 | — |
| Interest & Investment Income | 27.1 | 21.9 | 18.5 | 14.7 | 3.1 | 0.2 | — |
| Net Interest Expenses | — | — | — | 9.0 | 15.7 | 24.0 | — |
| EBT, Incl. Unusual Items | 233.0 | 215.1 | 191.8 | 173.4 | 104.7 | 37.4 | (36.9) |
| Income Tax Expense | 54.4 | 56.4 | 46.3 | 44.5 | (76.8) | 2.8 | — |
| Net Income | |||||||
| Net Income | 178.6 | 158.7 | 145.5 | 128.9 | 181.5 | 34.6 | (36.9) |
| Per Share | |||||||
| Basic EPS | 3.06 | 2.76 | 2.56 | 2.17 | 3.07 | 0.60 | (2.48) |
| Diluted EPS | 2.99 | 2.71 | 2.51 | 2.13 | 2.97 | 0.58 | (2.48) |
| Revenue per Share | 16.58 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 58.4 | 57.5 | 56.9 | 59.5 | 59.2 | 57.5 | 25.8 |
| Diluted Weighted Avg Shares | 59.7 | 58.5 | 57.9 | 60.4 | 61.1 | 59.2 | 25.8 |
| Supplemental | |||||||
| EBIT | 219.4 | 208.5 | 190.8 | 192.0 | 120.2 | 87.5 | 17.0 |
| Effective Tax Rate | 23.3% | — | — | 25.7% | -73.3% | 7.6% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.